symbol-NAM

NAM NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED

NAM
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED
3.80
+0.14 (+3.83%)
High3.80
Low3.66
Total Vol7,500
Total Val(K)28.00
Description
Manufacturing, importing and distributing of medical devices for sterilizing medical equipment including medical consumables thereof as well as providing any or all related services

Overview


  • SymbolNAM
  • Market Cap (M.Bath)2,562.00
  • IPO Date31 Oct 2023
  • IPO Price7.70 @Par Value 0.50 Baht
  • CEOGEN. WINAI PHATTIYAKUL
  • Employees-
  • IndustryCONSUMP
  • SectorPERSON
  • Index-
  • SET ESG Ratings-

สรุปภาพรวมตลาด

Period
Ex-Date
Record Date
Shareholders List Date
Dividend Payment Date
Type
Dividend (Baht/Share)
Unit
Financial Period
Dividend From
13 Mar 2026
-
16 Mar 2026
15 May 2026
Cash Dividend
0.03 Baht
Baht
01 Jan 2025 - 31 Dec 2025
Net profit
27 Nov 2025
-
28 Nov 2025
12 Dec 2025
Cash Dividend
0.10 Baht
Baht
01 Jan 2025 - 30 Sep 2025
Net profit and retained earnings
14 Mar 2025
-
17 Mar 2025
16 May 2025
Cash Dividend
0.15 Baht
Baht
01 Jan 2024 - 31 Dec 2024
Net profit
11 Mar 2024
-
12 Mar 2024
17 May 2024
Cash Dividend
0.09 Baht
Baht
01 Jan 2023 - 31 Dec 2023
Net profit and retained earnings
Note
Approximate Date Shows ex-rights and ex-dividend marks and entitlements over the past 5 years

Key Issues

Upcoming Event

Relate Stock Sectors

Check out other big names from the same Sectors NAM

symbol-https://s3.efinancethai.com/symbols-logo/NAM.pngNAM
efin Focus Metrics
Quarter 4/2025
Z-Score
3.05
4.13
2.96
Monitor C-Score
0.00
0.00
0.00
ICR
7.39
-206.99
9.74
DSCR
0.00
-0.94
1.43
EV/EBITDA
244,243.95
7.93
11.14
FCF Yield
0.00
0.00
16.66
FCF/Net Income
0.00
0.00
3.38
Net Debt/EBITDA
0.00
0.52
0.33
ROIC
9.35
36.79
6.69
Valuation Metrics
Last Price
3.80
4.64
4.08
P/E
24.12
7.83
22.75
P/BV
1.22
2.46
1.35
Dividend Yield
4.29
8.79
0.00
Financial Strength
D/E
0.45
0.89
0.41
Current Ratio
2.94
2.13
1.73
Net Profit Margin
6.44
15.16
6.15
ROE/ROA
0.83
1.56
1.00
Growth Metrics
Revenue Growth YoY
21.66
-19.19
7.56
Revenue Growth 3Y
0.00
81.11
29.04
Revenue Growth 3Y CAGR
0.00
21.89
8.87
Revenue per Share
0.00
0.00
0.00
EPS Growth
-45.62
-29.75
78.47
EBITDA Growth
-10.76
31.68
66.94
5Y CAGR Total Return
0.00
18.86
-19.07
Market Cap (M.Bath)
2,450.00
2,390.93
2,784.58
Average Volume
335.07
4,792.05
3,249.85

efin Focus Metrics

Quarter 4/2025
Z-Score
Monitor C-Score
ICR
DSCR
EV/EBITDA
FCF Yield
FCF/Net Income
Net Debt/EBITDA
ROIC
Z-Score
xxx
xxx
xxx
Monitor C-Score
xxx
xxx
xxx
ICR
xxx
xxx
xxx
DSCR
xxx
xxx
xxx
EV/EBITDA
xxx
xxx
xxx
FCF Yield
xxx
xxx
xxx
FCF/Net Income
xxx
xxx
xxx
Net Debt/EBITDA
xxx
xxx
xxx
ROIC
xxx
xxx
xxx

Valuation Metrics

Last Price
3.80
4.64
4.08
P/E
24.12
7.83
22.75
P/BV
1.22
2.46
1.35
Dividend Yield
4.29
8.79
0.00

Financial Strength

D/E
0.45
0.89
0.41
Current Ratio
2.94
2.13
1.73
Net Profit Margin
6.44
15.16
6.15
ROE/ROA
0.83
1.56
1.00

Growth Metrics

Revenue Growth YoY
21.66
-19.19
7.56
Revenue Growth 3Y
0.00
81.11
29.04
Revenue Growth 3Y CAGR
0.00
21.89
8.87
Revenue per Share
0.00
0.00
0.00
EPS Growth
-45.62
-29.75
78.47
EBITDA Growth
-10.76
31.68
66.94
5Y CAGR Total Return
0.00
18.86
-19.07
Market Cap (M.Bath)
2,450.00
2,390.93
2,784.58
Average Volume
335.07
4,792.05
3,249.85
Note
  • Calculated using adjusted prices.
  • Data is shown and calculated based on consolidated financial statements, presented as year-to-date quarterly figures. (If consolidated statements are unavailable, company-only statements are used.)
  • Financial data is updated quarterly within 7 business days after new statements are released.
  • Financial statement data reflects what listed companies submit for each period. Users should review the full financial statements for details, as some companies may revise comparative figures in the latest full version.
  • The list of companies included in the SETESG Index is announced together with other indices, based on the latest SET ESG Ratings results. Source: www.set.or.th (Copyright @ The Stock Exchange of Thailand).